|
[1]GONZALEZ FJ, SHAH YM.PPAR alpha:mechanism of species differences and hepatocarcino genesis of peroxisome proliferators[J].Toxicology, 2008, 246 (1) :2-8.
|
|
[2]FILIP-CIUBOTARU F, FOIA L, MANCIUC C, et al.PPARs:structure, mechanisms of action and control.NoteI[J].Rev Med Chir Soc Med Nat Lasi, 2011, 115 (2) :477-484.
|
|
[3]MANDRUP S, LANE MD.Regulating adipogenesis[J].J Biol Chem, 1997, 272:5367-5370.
|
|
[4]MARCUS SL, MIYATA KS, ZHANG BW, et al.Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferatorresponsive elements of the rat hydratase/de-hydroganase and fatty acyl-CoA oxidase genes but diferentially induce expression[J].Proc Natl Acad Sci U S A, 1993, 90 (12) :5723-5727.
|
|
[5]DREYER C, KREY G, KELLER H, et al.Control of the peroxisomeβoxidation pathway by a novel family of nuclear hormone receptors[J].Cell, 1992, 68 (5) :879-887.
|
|
[6]BERGER J, MOLLER DE.The mechanisms of action of PPARs[J].Annu Rev Med, 2002, 53:409-435.
|
|
[7]REDDY RC.Immunomodulatory role of PPAR-gamma in alveolar macrophages[J].J Investig Med, 2008, 56 (2) :522-527.
|
|
[8]GHOSH AK, WEI J, WU MH, et al.Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator activated receptor-gamma[J].Biochem Biophys Res Commun, 2008, 374 (2) :231-236.
|
|
[9]SOUPENE E, KUYPERS FA.Mammalian long-chain acyl-CoA synthetases[J].Exp Biol Med (Maywood) , 2008, 233 (5) :507-521.
|
|
[10]LI LO, KLETT L, COLEMAN RA.Acyl-CoA synthesis, lipid metabolism and lipotoxicity[J].Biochim Biophys Acta, 2010, 1801 (3) :246-251.
|
|
[11]LI LO, MASHEK DG, AN J, et al.Overexpression of rat long chain acyl-CoA synthetase 1 alters fatty acid metabolism in rat primary hepatocytes[J].J Biol Chem, 2006, 281 (48) :37246-37255.
|
|
[12]MUOIO DM, LEWIN TM, WIEDMER P, et al.Acyl-CoAs are functionally channeled in liver:potential role of acyl-CoA synthetase[J].Am J Physiol Endocrinol Metab, 2000, 279 (6) :1366-1373.
|
|
[13]FU M, ZHANG J, LIN Y, et al.Eady growth response factor-1 is a critical transcriptional mediator of peroxisome proliferator-activated receptor-γ/1 gene expression in human aortic smooth muscle cells[J].J Biol Chem, 2002, 277 (30) :26808-26814.
|
|
[14]IP E, FARRELL GC, ROBERTSO G, et al.Central role of PPAR alpha dependent hepatic lipid turnover in dietary steatohepatitis in mice[J].Hepatology, 2003, 38 (1) :123-132.
|
|
[15]REDDY JZ.Nonalcoholic steatosis and steatohepatitis.Ⅲ.Pemxisomal beta-oxidation, PPAR alpha, and steatohepatitis[J].Am J Physiol Gastmintest Liver Physiol, 2001, 281 (6) :1333-1339.
|
|
[16]CARPINO G, MORIN S, GINANNI CORRADINI S, et al.Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurent chronic hepatitis after liver transplantation[J].Dig Liver Dis, 2005, 37 (5) :349-356.
|
|
[17]UTO H, NAKANISHI L, IDO A, et al.The peroxisome proliferator-activated receptor-gamma agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, l-amino acid-defined diet[J].Hepatol Res, 2005, 32 (4) :235-242.
|
|
[18]LI LO, ELLIS M, HEATHER A, et al.Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis andβ-Oxidation and alters phospholipid fatty acid composition[J].J Biol Chem, 2009, 284 (41) :27816-27826.
|
|
[19]DENG YH, SHEN N, LING N, et al.Efficacy of the Gurc-OEG on rat liver fibrosis induced by CCl4[J].Chin J Clin Pharmacol Ther, 2012, 17 (2) :147-153. (in Chinese) 邓燕红, 沈能, 凌宁, 等.姜黄素衍生物对四氯化碳诱导肝纤维化的治疗作用[J].中国临床药理学与治疗学, 2012, 17 (2) :147-153.
|
|
[20]LU LG, LI ZH.Recent research on liver fibrosis and cirrhosis[J].J Clin Hepatol, 2013, 29 (5) :321-323. (in Chinese) 陆伦根, 李郑红.肝纤维化及肝硬化近况研究[J].临床肝胆病杂志, 2013, 29 (5) :321-323.
|
DownLoad: